Crossmark

Quality by design (QbD) approach to develop fast-dissolving tablets using melt-dispersion paired with surface-adsorption method: formulation and pharmacokinetics of flurbiprofen melt-dispersion granules

Crossref DOI link: https://doi.org/10.1007/s13346-023-01382-z

Published Online: 2023-07-17

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vemula, Sateesh Kumar

Daravath, Bhaskar

Repka, Michael
License Information

Text and Data Mining valid from 2023-07-17

Version of Record valid from 2023-07-17
More Information

Article History

Accepted: 19 June 2023

First Online: 17 July 2023

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. The in vivo bioavailability studies are approved by the institutional animal ethical committee (IAEC Approval No: CPCSEA/IAEC/JLS/006/02/17/006). All institutional and national guidelines for the care and use of laboratory animals were followed.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below